EquityZen Growth Technology Fund LLC - Series 859
Raised
$930K
Investors
38
Min Invest
$10,006
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 859 is a Delaware-based pooled investment vehicle focused on pre-IPO technology securities, filed by EquityZen Advisors LLC on 2021-05-25. The fund raised $930K from 38 investors under Rule 506(b), with a $10K minimum investment. This entity is part of the EquityZen platform, which operates 1,889 related series vehicles for secondary pre-IPO investments.
This pre-IPO fund follows the standard EquityZen series SPV model, using Rule 506(b) to pool accredited investors into single-company exposures at a $10K minimum entry point. The relatively low minimum and high investor count (38 participants for $930K raised, averaging ~$24K per investor) is typical for democratized pre-IPO access platforms targeting retail accredited investors.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
